BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 28551378)

  • 1. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors.
    Kimura N; Young AL; Toyoki Y; Wyatt JI; Toogood GJ; Hidalgo E; Prasad KR; Kudo D; Ishido K; Hakamada K; Lodge JPA
    Surgery; 2017 Sep; 162(3):500-514. PubMed ID: 28551378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection and drainage of hilar cholangiocarcinoma: an 11-year experience of a single center in mainland China.
    Zheng-Rong L; Hai-Bo Y; Xin C; Chuan-Xin W; Zuo-Jin L; Bing T; Jian-Ping G; Sheng-Wei L
    Am Surg; 2011 May; 77(5):627-33. PubMed ID: 21679599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
    Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining enhanced recovery after resection of peri-hilar cholangiocarcinoma.
    Quinn LM; Mann K; Jones RP; Bathla S; Stremitzer S; Dunne DF; Lacasia C; Fenwick SW; Malik HZ
    Eur J Surg Oncol; 2019 Aug; 45(8):1439-1445. PubMed ID: 30979508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
    Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
    Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
    Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinoma.
    Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    Surgery; 2017 Feb; 161(2):394-404. PubMed ID: 27712872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left hepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma: A retrospective cohort study.
    Peng C; Li C; Wen T; Yan L; Li B
    Int J Surg; 2016 Aug; 32():167-73. PubMed ID: 27344254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
    Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of portal vein resection on oncologic long-term outcome in patients with hilar cholangiocarcinoma.
    Hoffmann K; Luible S; Goeppert B; Weiss KH; Hinz U; Büchler MW; Schemmer P
    Surgery; 2015 Nov; 158(5):1252-60. PubMed ID: 26216010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant Precise Hemihepatectomy to Improve the Efficacy of Surgical Treatment for Hilar Cholangiocarcinoma: Analysis of 38 Cases.
    Wang L; Geng ZM; Song XG; Zhao YL; Noor H; Shi L; Liu QG
    Hepatogastroenterology; 2014 Jun; 61(132):927-32. PubMed ID: 26158143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right-side versus left-side hepatectomy for the treatment of hilar cholangiocarcinoma: a comparative study.
    Jo HS; Kim DS; Yu YD; Kang WH; Yoon KC
    World J Surg Oncol; 2020 Jan; 18(1):3. PubMed ID: 31901228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.
    Dekker AM; Wiggers JK; Coelen RJ; van Golen RF; Besselink MG; Busch OR; Verheij J; Hollmann MW; van Gulik TM
    HPB (Oxford); 2016 Mar; 18(3):262-70. PubMed ID: 27017166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
    Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
    World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma.
    Zhang XF; Bagante F; Chen Q; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    Surgery; 2018 May; 163(5):1114-1120. PubMed ID: 29398035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center.
    Ercolani G; Zanello M; Grazi GL; Cescon M; Ravaioli M; Del Gaudio M; Vetrone G; Cucchetti A; Brandi G; Ramacciato G; Pinna AD
    J Hepatobiliary Pancreat Sci; 2010 May; 17(3):329-37. PubMed ID: 20464563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
    Lee SG; Song GW; Hwang S; Ha TY; Moon DB; Jung DH; Kim KH; Ahn CS; Kim MH; Lee SK; Sung KB; Ko GY
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):476-89. PubMed ID: 19851704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.